In 2024, SIA "Solepharm" had revenue of 4.1 million EUR and profit of 383.5 thousand EUR. The company has 10 employees. Beneficial owners: Juris Ozols, Kaspars Ivanovs.
| year | 2024Latest | 2023 | 2022 |
|---|---|---|---|
Revenue | 4,1m € +1.5% | 4m € +24.3% | 3,3m € +58.2% |
Profit | 383,5k € +22.1% | 314,2k € +66.4% | 188,8k € -32.4% |
Assets | 1,9m € -0.5% | 1,9m € +33.6% | 1,4m € +36.4% |
Liabilities | 776,1k € -10.8% | 869,6k € +86.4% | 466,5k € +66.6% |
Equity | 1,1m € +8.3% | 1m € +7.4% | 941k € +25.1% |
Employees | 10 -9.1% | 11 -15.4% | 13 +30.0% |
Overall rating | A+95/100 |
Financial health | 100/100 |
Credit history | 100/100 |
Legal history | 100/100 |
Business activity | 70/100 |
| Overall risk | Low |
No risk flags | |
No tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| Board member | Independently |
SIA "Solepharm" is located at Mārupes nov., Mārupes pag., Jaunmārupe, Alkšņu iela 4, LV-2166.
In 2024, SIA "Solepharm" had revenue of 4 110 535 EUR and profit of 383 542 EUR. Compared to previous year, revenue increased by 1.5%. View full financial report →
In 2024, SIA "Solepharm" had an average of 10 employees. View tax history →
The beneficial owners of SIA "Solepharm" are Juris Ozols and Kaspars Ivanovs. View ownership details →
Yes, SIA "Solepharm" is registered as an active VAT payer with VAT number LV40103209086.
In 2024, the average gross salary at SIA "Solepharm" was approximately 2168,77 € per month (net ~ 1576,13 €). This is an approximate calculation. View salary details →
SIA "Solepharm" was founded on January 8, 2009. The company has been operating for 17 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 17 years | 6 - 10 | 68% | |
Net revenue | 4 110 535,00 € | 3 - 7 | 79% | |
Profit | 383 542,00 € | 2 - 6 | 86% | |
Equity | 1 094 111,00 € | 3 - 7 | 76% | |
Assets | 1 870 222,00 € | 3 - 7 | 82% | |
Fixed assets | 70 571,00 € | - | 60% | |
Liquidity | 2.41 | - | 75% | |
Profitability | 9.3% | - | 10% | |
Registered capital | 30 000,00 € | - | 75% |
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Annual financial report for 2019.
Registered in the Latvian company register.
| Name, surname | Shares | Ownership rights | |
|---|---|---|---|
| SIA "Solepharm Pharmaceuticals" | 30 000 | 100.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Juris Ozols | LV | ||
| Kaspars Ivanovs | LV |